The House Energy and Commerce Committee today held a hearing on the administration’s progress in carrying out provisions of the Comprehensive Addiction and Recovery Act and the 21st Century Cures Act, enacted last year to address the opioid epidemic. Lawmakers on both sides of the aisle criticized the Drug Enforcement Administration for delays in responding to committee inquiries about the agency’s enforcement of alleged “pill dumping” by manufacturers. Members also questioned federal agency heads about the higher cost of easily administered forms of opioid overdose reversal medicine, the percentage of addiction cases that are due to legally prescribed versus illegal drugs, and whether Congress should enact stronger criminal penalties for overprescribing of opioids. In a statement submitted to the committee, AHA recommended several federal actions to address the opioid crisis, including eliminating the Medicaid Institutions for Mental Disease exclusion for adults under age 65.

Related News Articles

Headline
AHA May 23 submitted recommendations to the Department of Justice and Federal Trade Commission in response to the agencies’ requests for information on…
Headline
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
The Trump administration May 5 issued two executive orders on pharmaceutical manufacturing and life-sciences research. The first executive order, "…
Headline
The Centers for Medicare & Medicaid Services today released a notice seeking public comment on the collection of information request regarding the State…
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…